Financhill
Back

Alkermes PLC Quote, Financials, Valuation and Earnings

Alkermes PLC Price Quote

$29.71

Alkermes PLC Key Stats

Buy
57
Alkermes PLC (ALKS) is a Buy

Day range:
$29.53 - $30.37
52-week range:
$22.90 - $32.88
Dividend yield:
0%
P/E ratio:
14.15
P/S ratio:
3.35
P/B ratio:
3.72%

Volume:
4.6M
Avg. volume:
1.7M
1-year change:
9.31%
Market cap:
$4.8B
Revenue:
$1.7B
EPS:
$1.95

How Much Does Alkermes PLC Make?

Data Unavailable

Is Alkermes PLC Growing As A Company?

Data Unavailable

Alkermes PLC Stock Price Performance

  • Did Alkermes PLC Stock Go Up Last Month?
    Alkermes PLC share price went up by 6.45% last month
  • Did ALKS's Share Price Rise Over The Last Year?
    ALKS share price rose by 9.31% over the past 1 year

What Is Alkermes PLC 52-Week High & Low?

Alkermes PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Alkermes PLC?

Data Unavailable

Is Alkermes PLC Cash Flow Positive?

Data Unavailable

Alkermes PLC Return On Invested Capital

Data Unavailable

Alkermes PLC Earnings Date & Stock Price

  • What Is Alkermes PLC's Stock Price Today?
    A single share of ALKS can be purchased today for 29.71
  • What Is Alkermes PLC’s Stock Symbol?
    Alkermes PLC trades on the nasdaq under the ticker symbol: ALKS
  • When Is Alkermes PLC’s Next Earnings Date?
    The next quarterly earnings date for Alkermes PLC is scheduled on February 14, 2025
  • When Is ALKS's next ex-dividend date?
    Alkermes PLC's next ex-dividend date is December 22, 2024
  • How To Buy Alkermes PLC Stock?
    You can buy Alkermes PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Alkermes PLC Competitors

  • Who Are Alkermes PLC's Competitors?
    Below is a list of companies who compete with Alkermes PLC or are related in some way:
    • Iterum Therapeutics PLC (ITRM)
    • Jazz Pharmaceuticals PLC (JAZZ)
    • Mallinckrodt PLC (MCKPF)
    • Medtronic PLC (MDT)
    • Perrigo Co PLC (PRGO)

Alkermes PLC Dividend Yield

Data Unavailable

Alkermes PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 96.43% 2.43%
Revenue: -0.73% -0.66%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 4
Sell Recommendations: 1
Price Target: 34.08
Upside from Last Price: 14.7%

Major Shareholders

Data Unavailable